Literature DB >> 8160547

Malignant mixed müllerian tumor of the fallopian tube.

C G Zorlu1, O Cobanoglu, E Kuşçu, D Aribas.   

Abstract

Primary malignant mixed müllerian tumor of the fallopian tube is uncommon. Only 37 cases of malignant mixed müllerian tumor of the fallopian tube have been reported to date and of these only 16 contained heterologous components (mesodermal mixed tumor). This rarity made us report a case of malignant mixed müllerian tumor of the fallopian tube containing heterologous components which was operated on in our gynecologic oncology department. Postoperatively the patient was placed on six courses of adjuvant chemotherapy consisting of cis-platinum, adriamycin and cyclophosphamide (PAC). Second look laparotomy was performed after completion of chemotherapy. Presently, she is doing well, at two months follow-up, with no evidence of disease.

Entities:  

Mesh:

Year:  1994        PMID: 8160547     DOI: 10.3109/00016349409015779

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.

Authors:  Wakae Kawaguchi; Hiroaki Itamochi; Junzo Kigawa; Yasunobu Kanamori; Tetsuro Oishi; Muneaki Shimada; Shinya Sato; Seiya Sato; Naoki Terakawa
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

2.  Primary malignant mixed müllerian tumor of the fimbriated end of the fallopian tube causing hematosalpinx and hematometra.

Authors:  Dagistan Tolga Arioz; Sezgin Yilmaz; Nazan Okur; Fatma Aktepe; Mehmet Yilmazer; Sinan Ozalp
Journal:  N Am J Med Sci       Date:  2012-12

3.  Malignant mixed Müllerian tumor of the fallopian tube: Case report and literature review.

Authors:  Alexandra Lavinia Cozlea; Mihai Gheorghe; Szilard Leo Kiss; Anas Fandi; Mihai Stanca; Simona Mocan; Mihai Emil Căpîlna; Nicolae Bacalbașa; Andreea Anamaria Moldovan
Journal:  Exp Ther Med       Date:  2021-12-28       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.